Novo Nordisk Q3 results: Ozempic maker’s profit falls 27%; cuts 9,000 jobs
Novo Nordisk, maker of Ozempic and Wegovy, lowered its 2025 sales outlook for the fourth time, citing slower growth in diabetes and obesity treatments. The ...
Latest Post
India-US trade deal: How Delhi’s behind-the-scenes push cracked Trump tariff wall
India and the US have reached a surprising trade deal, reducing tariffs on Indian goods to 18% after a year of strained relations. National Security ...
US markets today: Wall street opens mixed as tech stocks weigh; gold climbs back above $5,000 per ounce
No valid response from Gemini.
Rail modernisation: Railways plans 260 Vande Bharat sleeper rakes; phased rollout with advanced safety, comfort features
No valid response from Gemini.
Is another repo rate cut on the table as RBI MPC meets? What to expect from Friday’s policy outcome
No valid response from Gemini.